Publications
- Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia2013 | Faculty of Medicine in Hradec Králové
- Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy2009 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB as a marker of cardiac toxicity during hematopoietic cell transplantation in hematooncology +12009 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity +12008 | Faculty of Medicine in Hradec Králové
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia +12008 | Faculty of Medicine in Hradec Králové
- Biochemical markers in the diagnostics of cardiovascular toxicity of hematooncology treatment in year 2008 +12008 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation +12007 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation2007 | Publication without faculty affiliation
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
Loading network view...